Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density
- PMID: 21365462
- PMCID: PMC3206165
- DOI: 10.1007/s00198-011-1560-y
Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density
Abstract
Introduction: In men, idiopathic osteoporosis (IOP) is often associated with low serum insulin-like growth factor (IGF-1) and reduced bone formation. The characteristics of premenopausal women with IOP are not well defined. We aimed to define the clinical, reproductive, and biochemical characteristics of premenopausal women with unexplained osteoporosis.
Methods: This is a cross-sectional study of 64 women with unexplained osteoporosis, 45 with fragility fractures, 19 with low bone mineral density (BMD; Z-score less than or equal to -2.0) and 40 normal controls. The following are the main outcome measures: clinical and anthropometric characteristics, reproductive history, BMD, gonadal and calciotropic hormones, IGF-1, and bone turnover markers (BTMs).
Results: Subjects had lower BMI and BMD than controls, but serum and urinary calcium, serum estradiol, vitamin D metabolites, IGF-1, and most BTMs were similar. Serum parathyroid hormone (PTH) and the resorption marker, tartrate-resistant acid phosphatase (TRAP5b), were significantly higher in both groups of subjects than controls and directly associated in all groups. Serum IGF-1 and all BTMs were directly associated in controls, but the association was not significant after controlling for age. There was no relationship between serum IGF-1 and BTMs in subjects. There were few differences between women with fractures and low BMD.
Conclusions: Higher serum TRAP5b and PTH suggest that increased bone turnover, possibly related to subclinical secondary hyperparathyroidism could contribute to the pathogenesis of IOP. The absence of differences between women with fractures and those with very low BMD indicates that this distinction may not be clinically useful to categorize young women with osteoporosis.
Conflict of interest statement
Figures



Similar articles
-
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.J Clin Endocrinol Metab. 2011 Oct;96(10):3095-105. doi: 10.1210/jc.2011-1387. Epub 2011 Aug 10. J Clin Endocrinol Metab. 2011. PMID: 21832117 Free PMC article.
-
Idiopathic osteoporosis in premenopausal women.Osteoporos Int. 2005 May;16(5):526-33. doi: 10.1007/s00198-004-1716-0. Epub 2004 Aug 5. Osteoporos Int. 2005. PMID: 15300364
-
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women.Bone. 2010 Jan;46(1):244-7. doi: 10.1016/j.bone.2009.10.011. Epub 2009 Oct 21. Bone. 2010. PMID: 19853071
-
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa306. doi: 10.1210/clinem/dgaa306. J Clin Endocrinol Metab. 2020. PMID: 32453819 Review.
-
Treatment of premenopausal women with low bone mineral density.Curr Osteoporos Rep. 2008 Mar;6(1):39-46. doi: 10.1007/s11914-008-0007-7. Curr Osteoporos Rep. 2008. PMID: 18430399 Free PMC article. Review.
Cited by
-
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.J Clin Endocrinol Metab. 2011 Oct;96(10):3095-105. doi: 10.1210/jc.2011-1387. Epub 2011 Aug 10. J Clin Endocrinol Metab. 2011. PMID: 21832117 Free PMC article.
-
Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.Bone. 2022 Jan;154:116253. doi: 10.1016/j.bone.2021.116253. Epub 2021 Nov 4. Bone. 2022. PMID: 34743040 Free PMC article.
-
Understanding the characteristics of idiopathic osteoporosis by a systematic review and meta-analysis.Endocrine. 2023 Dec;82(3):513-526. doi: 10.1007/s12020-023-03505-5. Epub 2023 Sep 21. Endocrine. 2023. PMID: 37733181
-
Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder.J Bone Joint Surg Am. 2013 Oct 2;95(19):e1391-6. doi: 10.2106/JBJS.L.01281. J Bone Joint Surg Am. 2013. PMID: 24088974 Free PMC article.
-
IGF-1 Receptor Expression on Circulating Osteoblast Progenitor Cells Predicts Tissue-Based Bone Formation Rate and Response to Teriparatide in Premenopausal Women With Idiopathic Osteoporosis.J Bone Miner Res. 2017 Jun;32(6):1267-1273. doi: 10.1002/jbmr.3109. Epub 2017 Mar 23. J Bone Miner Res. 2017. PMID: 28218468 Free PMC article.
References
-
- Ebeling PR. Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management. Drugs Aging. 1998;13:421–434. - PubMed
-
- Gennari L, Bilezikian JP. Osteoporosis in men. Endocrinol Metab Clin North Am. 2007;36:399–419. - PubMed
-
- Gourlay ML, Brown SA. Clinical considerations in premenopausal osteoporosis. Arch Intern Med. 2004;164:603–614. - PubMed
-
- Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Severe osteoporosis in men. Ann Intern Med. 1995;123:452–460. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous